Literature DB >> 3886685

Immunological consequence of renal transplantation and immunosuppression. I. Alterations in human natural killer-cell activity.

W C Waltzer, R J Bachvaroff, A Arnold, D Anaise, F T Rapaport.   

Abstract

The role and activity of natural killer (NK) cells following renal transplantation remain unknown. To monitor NK activity, a 51Cr release of K-562 targets in prednisone- and azathioprine-treated patients receiving renal allografts was utilized. In 18 patients in whom NK activity was measured prior to and after transplantation, a significant diminution in NK activity within 3 weeks following transplantation was demonstrated compared to pretransplant values (34.71 vs 12.20%, respectively; P less than 0.001). In 11 subjects who had NK activity assayed at various intervals after transplantation but not prior to allografting, mean NK values were markedly lower (mean, 14.2%) than those of normal volunteers or patients maintained on hemodialysis (P less than 0.001). The latter two control groups demonstrated no difference (P = NS) in mean NK activity (39.46 vs 35.82%, respectively). In 5 of the 29 patients evaluated with good long-term graft function (mean, 2.7 years), restitution of normal NK activity was demonstrated. In two patients with bacterial infections, NK activity increased from 39.29 to 51.7% and from 13.54 to 20.00%. After infection, these values were 35.3% in the former and 3.39% in the latter. Viral infection did not appear to affect NK activity significantly. NK activity was increased in only one of seven patients with documented rejection episodes. In three of such patients, NK activity declined significantly following pulse methylprednisolone therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 3886685     DOI: 10.1007/bf00915004

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  27 in total

Review 1.  Development of cancer as a complication of clinical transplantation.

Authors:  I Penn
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

2.  Natural killer cells in bone marrow transplantation.

Authors:  C Lopez; D Kirkpatrick; S Livnat; R Storb
Journal:  Lancet       Date:  1980-11-08       Impact factor: 79.321

3.  Natural NK-cell targets in the mouse thymus: characteristics of the sensitive cell population.

Authors:  M Hansson; K Kärre; R Kiessling; J Roder; B Andersson; P Häyry
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

4.  Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. II. "Specificities" of the natural killer cells.

Authors:  R M Welsh; R M Zinkernagel; L A Hallenbeck
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

5.  Natural killer cells.

Authors:  R B Herberman
Journal:  Hosp Pract (Hosp Ed)       Date:  1982-04

Review 6.  Natural killer cells and their possible relevance to transplantation biology.

Authors:  R B Herberman
Journal:  Transplantation       Date:  1982-07       Impact factor: 4.939

Review 7.  Do natural killer cells engage in regulated reactions against self to ensure homeostasis?

Authors:  G Cudkowicz; P S Hochman
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

8.  Selective depletion of human natural killer cells on monolayers of target cells.

Authors:  W H Phillips; J R Ortaldo; R B Herberman
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

9.  The effect of immunopharmacological agents on mouse natural cell-mediated cytotoxicity and on its augmentation by poly I:C.

Authors:  J Y Djeu; J A Heinbaugh; W D Vieira; H T Holden; R B Herberman
Journal:  Immunopharmacology       Date:  1979-06

10.  On the heterogeneity of murine natural killer cells.

Authors:  N Minato; L Reid; B R Bloom
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  2 in total

1.  Natural killer cell activity during measles.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

2.  Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production in cyclosporine-treated and conventionally immunosuppressed human allograft recipients.

Authors:  P J Guillou; G R Giles; C W Ramsden
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.